Andrea de Bartolomeis

Neuroscience University School of Medicine of Naples Federico II Italy 
Schizophrenia, psychosis, antipsychotics, synapse, Homer
"Andrea de Bartolomeis"

Andrea de Bartolomeis MD PhD Biosketch

Andrea de Bartolomeis M.D., Ph.D. is Associate Professor of Psychiatry, director of the Section of Psychiatry and Treatment Resistant Psychosis program at Department of Neuroscience, University School of Medicine of Napoli Federico II,
He is also the Director of the Residency program in Psychiatry

Andrea de Bartolomeis received his medical degree and his residency training in psychiatry at the University of Naples Federico II, Italy.

(Show more)

Mean distance: 17.93 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Buoli M, Cesana BM, Fagiolini A, et al. (2020) Which factors delay treatment in bipolar disorder? A nationwide study focussed on duration of untreated illness. Early Intervention in Psychiatry
Iasevoli F, Barone A, Buonaguro EF, et al. (2020) Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opinion On Drug Safety
Galletta D, Califano AI, Micanti F, et al. (2020) Cognitive correlates of borderline intellectual functioning in borderline personality disorder. Journal of Psychiatric Research. 130: 372-380
Fornaro M, Carvalho AF, Fusco A, et al. (2020) The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials. Journal of Affective Disorders. 276: 970-983
Maccariello G, Barbuti M, Vannucchi G, et al. (2020) Predictors of Depressive Switch in Patients With Bipolar I Disorder Who Initiated or Changed Pharmacologic Treatment for Mania or Mixed-Mania: A Prospective Observational Study. The Journal of Clinical Psychiatry. 81
Iasevoli F, Fornaro M, D'Urso G, et al. (2020) Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychological Medicine. 1-3
de Bartolomeis A, Avagliano C, Vellucci L, et al. (2019) Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia. Neuroscience and Biobehavioral Reviews
Buonaguro EF, Morley-Fletcher S, Avagliano C, et al. (2019) Glutamatergic postsynaptic density in early life stress programming: Topographic gene expression of mGlu5 receptors and Homer proteins. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109725
Polese D, Fornaro M, Palermo M, et al. (2019) Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis. Frontiers in Psychiatry. 10: 210
Buoli M, Cesana BM, Dell'Osso B, et al. (2019) Gender-related differences in patients with bipolar disorder: a nationwide study. Cns Spectrums. 1-8
See more...